We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Analysis of RNA Carried by Tumor-educated Platelets Yields Valuable Diagnostic Clues

By LabMedica International staff writers
Posted on 15 Nov 2015
Print article
Image: Three-dimensional rendition of human blood platelets (Photo courtesy of Wikimedia Commons).
Image: Three-dimensional rendition of human blood platelets (Photo courtesy of Wikimedia Commons).
Analysis of tumor RNA carried in the afflicted individual's blood platelets may be more useful than other "liquid biopsy" technologies for diagnosing cancer and determining its primary location and potential therapeutic approaches.

Tumor-educated blood platelets (TEPs), which have incorporated molecules shed by tumors, have been implicated as central players in the systemic and local responses to tumor growth, thereby altering their RNA profile.

Investigators at Massachusetts General Hospital (Boston, USA) evaluated the diagnostic potential of TEPs by mRNA sequencing of 283 platelet samples. They reported in the October 29, 2015, online edition of the journal Cancer Cell that after amplifying and sequencing the amount of platelet RNA found in the equivalent of a single drop of blood from each individual, they had identified more than 5,000 different platelet RNAs.

Comparing RNA profiles of healthy donors with those of 228 cancer patients revealed increased levels of nearly 1,500 different RNA molecules and decreased levels of almost 800. Analysis of the levels of around 1,000 RNAs from about 300 individuals with a dedicated algorithm that classified whether not they indicated the presence of cancer did so with 96% percent accuracy. All of the patients with localized tumors and 33 of the 39 with tumors of the central nervous system were accurately diagnosed. Across six different tumor types, the location of the primary tumor was correctly identified with 71% accuracy.

"By combining next-generation-sequencing gene expression profiles of platelet RNA with computational algorithms we developed, we were able to detect the presence of cancer with 96% accuracy," said contributing author Dr. Bakhos Tannous, associate professor of neurology at Massachusetts General Hospital. "Platelet RNA signatures also provide valuable information on the type of tumor present in the body and can guide selection of the most optimal treatment for individual patients.

"We observed that the mRNA profiles of tumor-educated platelets have the sensitivity and specificity to detect cancer, even in early, non-metastasized tumors," said Dr. Tannous. "We are further assessing the potential of TEP-based screening for therapeutic decision making and also investigating how noncancerous diseases may further influence the RNA repertoire of TEPs."

Related Links:
Massachusetts General Hospital


Gold Member
Hematology Analyzer
Swelab Lumi
Automated Blood Typing System
IH-500 NEXT
New
Silver Member
Benchtop Image Acquisition Device
Microwell Imager
New
Alpha-1-Antitrypsin ELISA
IDK alpha-1-Antitrypsin ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.